SCHEMBL20101951

SCHEMBL20101951

CNn1ccc(=O)c(C)c1C(=O)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
POLB P06746 2/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.37
KDM4E B2RXH2 5/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DAPK3 O43293 1/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
ABL1 P00519 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
MET P08581 1/20 0.34
PDGFRA P16234 1/20 0.34
PRKACA P17612 1/20 0.34
LTK P29376 1/20 0.34
GRK5 P34947 1/20 0.34
KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26301294 0.80 GAA (0.35) ALDH1A1POLBKMT2AGAAKDM4E
SCHEMBL20101952 0.78 ALDH1A1 (0.40) ALDH1A1POLBKMT2AGAAKDM4E
SCHEMBL25726383 0.70 MAPT (0.33) ALDH1A1POLBKMT2AGAAKDM4E
SCHEMBL28876470 0.62 TDP1 (0.37) ALDH1A1POLBKMT2AGAAKDM4E
SCHEMBL20998678 0.62 NPSR1 (0.42) ALDH1A1GAAKDM4EL3MBTL1DAPK3
SCHEMBL11286998 0.62 KDM4E (0.46) ALDH1A1GAAKDM4ETDP1DAPK3
SCHEMBL26301302 0.61 DAPK3 (0.35) ALDH1A1POLBKMT2AGAAKDM4E
SCHEMBL2446096 0.61 DAPK3 (0.41) ALDH1A1GAAKDM4ETDP1DAPK3
SCHEMBL13203325 0.60 MEN1 (0.57) ALDH1A1POLBKMT2AGAAKDM4E
SCHEMBL23748297 0.60 KDM4E (0.32) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118760-A1 SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF SHIONOGI & CO., LTD. (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118760-A1 SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF C3AR1, NR4A1, HAVCR2 ALDH1A1 1319/4885POLB 439/4885KMT2A 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.